COX4I1 and Alzheimer disease: ORAI2, RAB6A, and 7,981,324 are the top three biomarkers identified by LIME to predict frontal AD samples, and 79,814,324, 7,894,213, and COX4I1 for frontal non-AD samples with 0.97 and 0.96 probability respectively.